Bulk adverse event reporting may delay medical device safety warnings
Permitting medical device manufacturers to submit bulk summary reports of adverse events to the US Food and Drug Administration (FDA), rather than reporting individual cases, often fails to promptly detect potential safety signals, finds a study published by The BMJ today.
Read original article on The Medical News →Related news
-
Parents of kids who need complex medical care at home tend to resolve frequent safety issues on their own, study finds
-
The ACOTAR x Knix Collection Just Dropped, And These Are the Best Pieces to Buy
-
Lasers and Doppler effect could personalize chemotherapy drug selection for cancer tumors
-
AI detects daily stress by analyzing routine smartphone behaviors
-
Global study exposes gaps in global endometriosis care guidelines
-
Coffee drinkers had fewer repeat blood clots in a Norwegian study
-
Rapid growth in private testosterone prescribing raises safety concerns
-
Experts call for lifelong care after brain and spinal injuries